Eight participants achieved HBsAg loss at any time.Two participants met criteria for functional cure. Two participants who discontinued NUC ...

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use ...

Find out what everyone is searching for this year, from a Kendra Scott necklace to a Cuisinart ice cream maker.

Corporates may seem to be spoilt for choice when it comes to options for making cross-border payments, but with some schemes ...

Whether taking conference calls on the go or immersing yourself in your favourite album on a long walk, investing in a good ...